NCT04681807

Brief Summary

Social cognition is an individual's ability to perceive, process, understand, and react to other individuals in a social situation. Social cognition is impaired in individuals with schizophrenia, including difficulty recognizing others' emotions. A promising treatment avenue for emotion recognition problems in individuals with schizophrenia is continued practice with various facial expression recognition training programs. First degree relatives of someone with schizophrenia are considered at familial high risk (FHR) for the illness, because of its high level of heritability. It is therefore critical to explore if these emotion recognition training programs could also benefit people at FHR. In this current study, the investigators aim to explore the social-cognitive profiles and their neural correlates in FHR individuals. The investigators also aim to explore the potential efficacy of an emotion recognition intervention to improve this ability in FHR individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for not_applicable schizophrenia

Timeline
Completed

Started Jul 2021

Typical duration for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 18, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 23, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

July 21, 2021

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 22, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 22, 2025

Completed
Last Updated

January 2, 2026

Status Verified

December 1, 2025

Enrollment Period

4.1 years

First QC Date

December 18, 2020

Last Update Submit

December 29, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in emotion recognition performance from baseline - PENN Emotion Recognition Test

    Penn Emotion Recognition test - tests the participant's ability to recognize emotion from facial expressions

    baseline and post treatment (1 month)

  • Change in brain activity during emotion recognition tasks from baseline

    Brain activity as measured using task-based functional magnetic resonance imaging (fMRI).

    baseline and post treatment (1 month)

Study Arms (2)

Emotion Recognition Training

EXPERIMENTAL
Behavioral: Emotion Recognition Training

Control Training

OTHER

Control

Behavioral: Control Training

Interventions

Participants will undergo 2 fMRI scans, one before and one after the training sessions. There will be 4 visits consisting of an emotion recognition training exercise on iPad, lasting for a period of \~1 hour each. (More details about each condition will be added after study completion to protect the blinding of participants) .

Emotion Recognition Training

Participants will undergo 2 fMRI scans, one before and one after the training sessions. There will be 4 visits consisting of a control training exercise on iPad, lasting for a period of \~1 hour each. (More details about each condition will be added after study completion to protect the blinding of participants) .

Control Training

Eligibility Criteria

Age15 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Between (or equal to) 15-35 years of age
  • Ability to read/speak fluent English
  • Diagnosis of SZ, schizoaffective disorder or schizophreniform confirmed for 1st degree relative by referring psychiatrist or two reliable informants (using the adapted FIGS questionnaire).

You may not qualify if:

  • No diagnosis of psychosis related disorder
  • Significant neurological or medical disorders that may produce cognitive impairment
  • Current epilepsy or previous history of seizures
  • Previous head injury with current continuing symptoms (i.e., cognitive ability, dizziness, etc.)
  • Recent history of substance abuse or dependence (within past 3 months)
  • MRI contraindication (e.g. metallic head implant, history of seizure, pacemaker, pregnancy, etc.)
  • Current IQ \< 70 as measured by the Wechsler Abbreviated Scale of Intelligence Scale (WASI)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Royal Ottawa Mental Health Centre

Ottawa, Ontario, K1Z 7K4, Canada

Location

MeSH Terms

Conditions

Schizophrenia

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Due to the nature of the intervention, treatment administrators will not be able to remain blind to group assignment; however, assessment staff, investigators, and participants will be blind to group assignment. Assessment staff and investigators will never be involved in the randomization or treatment procedures.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients will be randomized to either 7 visits over a period of 1 month of an emotion recognition training condition or 7 visits over a period of one month of active control training condition.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 18, 2020

First Posted

December 23, 2020

Study Start

July 21, 2021

Primary Completion

August 22, 2025

Study Completion

August 22, 2025

Last Updated

January 2, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

De-identified data collected from this study may be shared with other researchers at the Royal's Institute of Mental Health Research for analyses and re-analyses. Variables of the study and scripts used for analyses will be made available to the public. De-identified data will also be shared with the general public upon request. Data that can connect with participants' identity will NOT be used or shared for analyses.

Shared Documents
SAP, ANALYTIC CODE
Time Frame
De-identified data will become available upon completion of the study and once results have been published in an academic journal (anticipated time frame: the year of 2026).

Locations